Patent · US Active

Immunomodulators

US11952434B2 · kind B2 · utility

0Cited by
17References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 20, 2022
Grant dateApr 9, 2024
Priority date
Expiry dateApr 20, 2042

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure provides compounds which are immunomodulators and thus are useful for the amelioration of various diseases, including cancer and infectious diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.